[1]
|
International Diabetes Federation (2009) IDF Diabetes atlas. 4th Edition, International Diabetes Federation.
|
[2]
|
Kohen, D., Burgess, A.P., Catalan, J. and Lant, A. (1998) The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Quality of Life Research, 7, 197-204.
doi:10.1023/A:1008817812520
|
[3]
|
Polonsky, W.H. (2002) Emotional and quality of life aspects of diabetes management. Current Diabetes Reports, 2, 153. doi:10.1007/s11892-002-0075-5
|
[4]
|
Wexler, D.J., Grant, R.W., Wittenberg, E., Bosch, J.L., Cagliero, E., Delahanty, L., et al. (2006) Correlates of health related quality of life in type 2 diabetes. Diabetologia, 49, 1489-1497. doi:10.1007/s00125-006-0249-9
|
[5]
|
Meadows, K.A., Abrams, C. and Sandbaek, A. (2000) Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with type 2 diabetes mellitus: Psychometric evaluation and cross-cultural comparison. Diabetic Medicine, 17, 572-580.
doi:10.1046/j.1464-5491.2000.00322.x
|
[6]
|
Meadows, K.A., Steen, N., McColl, E., Eccles, M., Shields, C., Hewison, J., et al. (1996) The Diabetes Health Profile (DHP): A new instrument for assessing the psychosocial profile of insulin requiring patients—Development and psychometric evaluation. Quality of Life Research, 5, 242- 254. doi:10.1007/BF00434746
|
[7]
|
Bradley, C., Todd, C., Gorton, T., Symonds, E., Martin, A. and Plowright, R. (1990) The development of an individualised questionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL. Quality of Life Research, 8, 79-91. doi:10.1023/A:1026485130100
|
[8]
|
Boyer, J.G. and Earp, J.A.L. (1997) The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Medical Care, 35, 440-453.
doi:10.1097/00005650-199705000-00003
|
[9]
|
Bott, U., Muhlhauser, H., Overmann, H. and Berger, M. (1998) Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetic Care, 21, 757-769. doi:10.2337/diacare.21.5.757
|
[10]
|
Bott, U., Ebrahim, S., Hirschberger, S. and Scovlund, S.E. (2003) Effect of rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes. Diabetic Medicine, 20, 626- 634. doi:10.1046/j.1464-5491.2003.01010.x
|
[11]
|
Achhab, Y.E., Nejjari, C., Chikri, M. and Lyoussi, B. (2008) Disease-specific health-related quality of life instruments among adult diabetics: A systematic review. Diabetes Research and Clinical Practice, 80, 171-184.
doi:10.1016/j.diabres.2007.12.020
|
[12]
|
Garratt, A.M., Schmidt, L. and Fitzpatrick, R. (2002) Partient-assessed health outcome measures for diabetes: A structured review. Diabetic Medicine, 19, 1-11.
doi:10.1046/j.1464-5491.2002.00650.x
|
[13]
|
Brooks, R. (1996) EuroQol: The current state of play. Health Policy, 37, 53-72.
doi:10.1016/0168-8510(96)00822-6
|
[14]
|
Dolan, P. (1997) Modeling valuations for EuroQol health states. Medical Care, 35, 1095-1108.
doi:10.1097/00005650-199711000-00002
|
[15]
|
Brazier, J., Roberts, J. and Deverill, M. (2002) The estimation of a preference-based measure of health from the SF 36. Journal of Health Economics, 21, 271-292.
doi:10.1016/S0167-6296(01)00130-8
|
[16]
|
Brazier, J.E. and Roberts, J. (2004) Estimating a preference-based index from the SF-12. Medical Care, 42, 851- 859. doi:10.1097/01.mlr.0000135827.18610.0d
|
[17]
|
Janssen, M.F., Lubetkin, E.L., Sekhobo, J.P. and Pickard, A.S. (2011) The use of the EQ-5D preference-based health status measure in adults with type 2 diabetes mellitus. Diabetic Medicine, 28, 395-413.
doi:10.1111/j.1464-5491.2010.03136.x
|
[18]
|
Solli, O., Stavem, K. and Kristiansen, I.S. (2010) Health- related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes, 8, 18. doi:10.1186/1477-7525-8-18
|
[19]
|
Kontodimopoulos, N., Pappa, E., Chadjiapostolou, Z., Arvanitaki, E., Papadopoulos, A.A. and Niakas, D. (2012) Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. European Journal of Health Economics, 13, 111-120.
doi:10.1007/s10198-010-0290-y
|
[20]
|
Guyatt, G.H., Osoba, D., Wu, A.W., Wyrwich, K.W. and Norman, G.R. (2002) Methods to explain the clinical significance of health status measures. Mayo Clinical Procedures, 77, 371-383. doi:10.4065/77.4.371
|
[21]
|
Revicki, D., Hays, R.D., Cella, D. and Sloan, J. (2008) Recommended methods for determining responsiveness and minimally important differences for patient reported outcomes. Journal of Clinical Epidemiology, 61, 102-109.
doi:10.1016/j.jclinepi.2007.03.012
|
[22]
|
Turner, D., Schumemann, H.J., Griffith, L.E., Beaton, D.E., Griffiths, A.M., Critch, J.N. and Guyatt, G.H. (2010) The minimum detectable change cannot reliably replace the minimal important difference. Journal of Clinical Epidemiology, 63, 28-36.
doi:10.1016/j.jclinepi.2009.01.024
|
[23]
|
Wyrwich, K.W., Norquist, J.M., Lenderking, W.R. and Acaster, S. (2013) Method for interpreting change over time in patient-reported outcome measures. Quality of Life Research, 22, 475-483.
|
[24]
|
Lemieux, J., Beaton, D.E., Hogg-Johnson, S., Bordeleau, L.J. and Goodwin, P.J. (2007) Three methods for minimally important difference: No relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology, 60, 448-455.
doi:10.1016/j.jclinepi.2006.08.006
|
[25]
|
Rejas, J., Pardo, A. and Angel Ruiz, M. (2008) Standard error of measurement as a valid alternative to minimally important difference for evaluation the magnitude of changes in patient-reported outcomes measures. Journal of Clinical Epidemiology, 61, 350-356.
doi:10.1016/j.jclinepi.2007.05.011
|
[26]
|
Huang, I.C., Liu, J.H., Wu, A.W., Wu, M.Y., Leite, W. and Hwang, C. (2008) Evaluating the reliability, validity, and minimal important difference of the Taiwanese version of the diabetes quality of life (DQOL) measurement. Health and Quality of Life Outcomes, 6, 87.
doi:10.1186/1477-7525-6-87
|
[27]
|
Walters, S.J. and Brazier, J.E. (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14, 1523-1532. doi:10.1007/s11136-004-7713-0
|
[28]
|
Pickard, A.S., Neary, M.P. and Cella, D. (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes, 8, 4. doi:10.1186/1477-7525-8-4
|
[29]
|
Walters, S.J. and Brazier, J.E. (2003) What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality of Life Outcomes, 1, 4.
doi:10.1186/1477-7525-1-4
|
[30]
|
Farr, A.A., Philips, C.J., Davies, S. and Morgan, S. (2010) Changes in health status of diabetic patients in Bridgend —Final report. Swansea University, Swansea.
|
[31]
|
Landorf, K.B., Radford, J.A. and Hudson, S. (2010) Minimal Important Difference (MID) of two commonly used outcome measures for foot problems. Journal of Foot and Ankle Research, 3, 7.
doi:10.1186/1757-1146-3-7
|
[32]
|
Farivar, S.S., Liu, H. and Hays, R.D. (2004) Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Review of Pharmacoeconomics and Outcomes Research, 4, 515-523.
doi:10.1586/14737167.4.5.515
|
[33]
|
Crosby, R.D., Kolotkin, R.L. and Williams, G.R. (2004) An integrated method to determine meaningful changes in health-related quality of life. Journal of Clinical Epidemiology, 57, 1153-1160.
doi:10.1016/j.jclinepi.2004.04.004
|
[34]
|
Norman, G.R., Sloan, J.A. and Wywrich, K.W. (2003) Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582-592.
doi:10.1097/01.MLR.0000062554.74615.4C
|
[35]
|
Cohen, J. (1988) Statistical power analysis for the behavioural sciences. 2nd Edition, Lawrence Erlbaum, Hillsdale.
|
[36]
|
Yost, K.J. and Eton, D.T. (2005) Combining distribution- and anchor-based approaches to determine minimally important difference: The FACIT experience. Evaluation and the Health Professions, 28, 172-191.
doi:10.1177/0163278705275340
|
[37]
|
Shikiar, R., Harding, G., Leahy, M. and Lennox, R.D. (2005) Minimal Important Difference (MID) of the Dermatology Life Quality Index (DLQI): Results from patients with chronic idiopathic urticaria. Health and Quality of Life Outcomes, 3, 36. doi:10.1186/1477-7525-3-36
|
[38]
|
Revicki, D.A., Cella, D., Hays, R.D., Sloan, J.A., Lenderking, W.R. and Aaronson, N.K. (2006) Responsiveness and minimal important differences for patient reported outcomes. Health and Quality of Life Outcomes, 4, 70. doi:10.1186/1477-7525-4-70
|